InvestorsHub Logo
Followers 17
Posts 1429
Boards Moderated 0
Alias Born 03/30/2013

Re: None

Tuesday, 07/12/2022 8:46:29 AM

Tuesday, July 12, 2022 8:46:29 AM

Post# of 428011
This strategy to bring death to Amarin by Mineral Oil controversy is probably paid for by the generics who want to disqualify the cardiovascular protection benefit of Vascepa and make Vascepa ONLY about lowering triglycerides. That way, though untrue, they can steal the whole market away from Amarin.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News